UBS Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.3M Buy
552,343
+48,180
+10% +$988K ﹤0.01% 2320
2025
Q1
$10.3M Buy
504,163
+75,373
+18% +$1.54M ﹤0.01% 2330
2024
Q4
$9.7M Sell
428,790
-3,954
-0.9% -$89.5K ﹤0.01% 2367
2024
Q3
$10.7M Buy
432,744
+95,488
+28% +$2.35M ﹤0.01% 1632
2024
Q2
$7.8M Buy
337,256
+13,370
+4% +$309K ﹤0.01% 1785
2024
Q1
$7.8M Buy
323,886
+206,310
+175% +$4.97M ﹤0.01% 1797
2023
Q4
$2.71M Buy
117,576
+1,241
+1% +$28.6K ﹤0.01% 2570
2023
Q3
$2.37M Buy
116,335
+5,267
+5% +$107K ﹤0.01% 2415
2023
Q2
$2.59M Buy
111,068
+4,938
+5% +$115K ﹤0.01% 2479
2023
Q1
$2.47M Sell
106,130
-8,903
-8% -$207K ﹤0.01% 2407
2022
Q4
$2.9M Sell
115,033
-31,183
-21% -$785K ﹤0.01% 2258
2022
Q3
$3.86M Sell
146,216
-9,580
-6% -$253K ﹤0.01% 1897
2022
Q2
$4.5M Sell
155,796
-31,682
-17% -$916K ﹤0.01% 1840
2022
Q1
$6.46M Sell
187,478
-120,603
-39% -$4.16M ﹤0.01% 1732
2021
Q4
$13.5M Buy
308,081
+78,614
+34% +$3.44M ﹤0.01% 1343
2021
Q3
$11.6M Sell
229,467
-6,768
-3% -$343K ﹤0.01% 1430
2021
Q2
$12.3M Buy
236,235
+448
+0.2% +$23.3K ﹤0.01% 1376
2021
Q1
$10.8M Buy
235,787
+49,022
+26% +$2.24M ﹤0.01% 1397
2020
Q4
$8.58M Buy
186,765
+99,284
+113% +$4.56M ﹤0.01% 1479
2020
Q3
$3.41M Buy
87,481
+87,469
+728,908% +$3.41M ﹤0.01% 1992
2020
Q2
$0 Buy
+12
New ﹤0.01% 7174
2020
Q1
Sell
-300
Closed -$9K 7098
2019
Q4
$9K Buy
300
+232
+341% +$6.96K ﹤0.01% 6257
2019
Q3
$2K Sell
68
-22
-24% -$647 ﹤0.01% 6758
2019
Q2
$2K Buy
+90
New +$2K ﹤0.01% 6738